Vericel (VCEL) Cash from Operations (2010 - 2026)
Vericel recorded quarterly Cash from Operations of 16383000.0 in Q1 2026, up 9.12% quarter-over-quarter from 15014000.0 in Q4 2025, and up 148.23% year-over-year from 6600000.0 in Q1 2025.
Vericel's Cash from Operations history runs 17 years deep, the most recent figure standing at 16383000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 148.23% year-over-year to 16383000.0; the TTM figure through Mar 2026 stood at 61693000.0 (up 7.18% YoY), while the FY2025 annual figure was 51910000.0, down 10.75% from the prior year.
- Cash from Operations came in at 16383000.0 for Q1 2026 at Vericel, up from 15014000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 22242000.0 in Q4 2024 to a low of 3143000.0 in Q2 2022.
- A 5-year average of 10556117.65 and a median of 8214000.0 in 2025 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations sank 65.62% in 2022 and surged 224.4% in 2023, its largest moves.
- Vericel's Cash from Operations stood at 6975000.0 in 2022, then jumped by 44.6% to 10086000.0 in 2023, then jumped by 120.52% to 22242000.0 in 2024, then plunged by 32.5% to 15014000.0 in 2025, then climbed by 9.12% to 16383000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 16383000.0, 15014000.0, and 22082000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.38 Mn |
| Mar 31, 2026 | 16.38 Mn |
| Dec 31, 2025 | 15.01 Mn |
| Dec 31, 2025 | 15.01 Mn |
| Sep 30, 2025 | 22.08 Mn |
| Sep 30, 2025 | 22.08 Mn |
| Jun 30, 2025 | 8.21 Mn |
| Jun 30, 2025 | 8.21 Mn |
| Mar 31, 2025 | 6.60 Mn |
| Mar 31, 2025 | 6.60 Mn |
| Dec 31, 2024 | 22.24 Mn |
| Dec 31, 2024 | 22.24 Mn |
| Sep 30, 2024 | 10.18 Mn |
| Sep 30, 2024 | 10.18 Mn |
| Jun 30, 2024 | 18.54 Mn |
| Jun 30, 2024 | 18.54 Mn |
| Mar 31, 2024 | 7.20 Mn |
| Mar 31, 2024 | 7.20 Mn |
| Dec 31, 2023 | 10.09 Mn |
| Dec 31, 2023 | 10.09 Mn |
| Sep 30, 2023 | 7.17 Mn |
| Sep 30, 2023 | 7.17 Mn |
| Jun 30, 2023 | 10.20 Mn |
| Jun 30, 2023 | 10.20 Mn |
| Mar 31, 2023 | 7.86 Mn |
| Mar 31, 2023 | 7.86 Mn |
| Dec 31, 2022 | 6.98 Mn |
| Dec 31, 2022 | 6.98 Mn |
| Sep 30, 2022 | 4.10 Mn |
| Sep 30, 2022 | 4.10 Mn |
| Jun 30, 2022 | 3.14 Mn |
| Jun 30, 2022 | 3.14 Mn |
| Mar 31, 2022 | 3.47 Mn |
| Mar 31, 2022 | 3.47 Mn |
| Dec 31, 2021 | 10.55 Mn |
| Dec 31, 2021 | 10.55 Mn |
| Sep 30, 2021 | 3.63 Mn |
| Sep 30, 2021 | 3.63 Mn |
| Jun 30, 2021 | 4.77 Mn |
| Jun 30, 2021 | 4.77 Mn |
| Mar 31, 2021 | 10.09 Mn |
| Mar 31, 2021 | 10.09 Mn |
| Dec 31, 2020 | 11.34 Mn |
| Dec 31, 2020 | 11.34 Mn |
| Sep 30, 2020 | 4.57 Mn |
| Sep 30, 2020 | 4.57 Mn |
| Jun 30, 2020 | -3.02 Mn |
| Jun 30, 2020 | -3.02 Mn |
| Mar 31, 2020 | 4.69 Mn |
| Mar 31, 2020 | 4.69 Mn |
| Dec 31, 2019 | 3.15 Mn |
| Dec 31, 2019 | 3.15 Mn |
| Sep 30, 2019 | 7.89 Mn |
| Sep 30, 2019 | 7.89 Mn |
| Jun 30, 2019 | -18.38 Mn |
| Jun 30, 2019 | -18.38 Mn |
| Mar 31, 2019 | 154,000.00 |
| Mar 31, 2019 | 154,000.00 |
| Dec 31, 2018 | 2.61 Mn |
| Dec 31, 2018 | 2.61 Mn |
| Sep 30, 2018 | 2.01 Mn |
| Sep 30, 2018 | 2.01 Mn |
| Jun 30, 2018 | -5.44 Mn |
| Jun 30, 2018 | -5.44 Mn |
| Mar 31, 2018 | 405,000.00 |
| Mar 31, 2018 | 405,000.00 |
| Dec 31, 2017 | 834,000.00 |
| Dec 31, 2017 | 834,000.00 |
| Sep 30, 2017 | -5.24 Mn |
| Sep 30, 2017 | -5.24 Mn |
| Jun 30, 2017 | -5.65 Mn |
| Jun 30, 2017 | -5.65 Mn |
| Mar 31, 2017 | -3.12 Mn |
| Mar 31, 2017 | -3.12 Mn |
| Dec 31, 2016 | -9.31 Mn |
| Dec 31, 2016 | -9.31 Mn |
| Sep 30, 2016 | -4.18 Mn |
| Sep 30, 2016 | -4.18 Mn |
| Jun 30, 2016 | -5.13 Mn |
| Jun 30, 2016 | -5.13 Mn |
| Mar 31, 2016 | -1.27 Mn |
| Mar 31, 2016 | -1.27 Mn |
| Dec 31, 2015 | -4.04 Mn |
| Dec 31, 2015 | -4.04 Mn |
| Sep 30, 2015 | -718,000.00 |
| Sep 30, 2015 | -718,000.00 |
| Jun 30, 2015 | -4.48 Mn |
| Jun 30, 2015 | -4.48 Mn |
| Mar 31, 2015 | -4.11 Mn |
| Mar 31, 2015 | -4.11 Mn |
| Dec 31, 2014 | -6.24 Mn |
| Dec 31, 2014 | -6.24 Mn |
| Sep 30, 2014 | -8.42 Mn |
| Sep 30, 2014 | -8.42 Mn |
| Jun 30, 2014 | -6.07 Mn |
| Jun 30, 2014 | -6.07 Mn |
| Mar 31, 2014 | -4.67 Mn |
| Mar 31, 2014 | -4.67 Mn |
| Dec 31, 2013 | -4.34 Mn |
| Dec 31, 2013 | -4.34 Mn |
| Sep 30, 2013 | -4.14 Mn |
| Sep 30, 2013 | -4.14 Mn |
| Jun 30, 2013 | -4.70 Mn |
| Jun 30, 2013 | -4.70 Mn |
| Mar 31, 2013 | -6.76 Mn |
| Mar 31, 2013 | -6.76 Mn |
| Dec 31, 2012 | -7.34 Mn |
| Dec 31, 2012 | -7.34 Mn |
| Sep 30, 2012 | -7.65 Mn |
| Sep 30, 2012 | -7.65 Mn |
| Jun 30, 2012 | -7.95 Mn |
| Jun 30, 2012 | -7.95 Mn |
| Mar 31, 2012 | -6.60 Mn |
| Mar 31, 2012 | -6.60 Mn |
| Dec 31, 2011 | -6.14 Mn |
| Dec 31, 2011 | -6.14 Mn |
| Mar 31, 2011 | -6.42 Mn |
| Mar 31, 2011 | -6.42 Mn |
| Sep 30, 2010 | -12.41 Mn |
| Sep 30, 2010 | -12.41 Mn |
| Jun 30, 2010 | -7.88 Mn |
| Jun 30, 2010 | -7.88 Mn |